Pregnancy Preterm Clinical Trial
Official title:
Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor
Verified date | March 2022 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
Status | Completed |
Enrollment | 91 |
Est. completion date | December 1, 2021 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | - Maternal age >18 years old - Pregnant mothers >13 weeks (home study only) - Pregnant mothers >26 weeks undergoing nonstress testing or delivering - Singleton pregnancy (inpatient or clinic visit patients only) - History of preterm labor or premature birth, active smoker, chronic condition (ex: HTN or DM), or an interval of less than 6 months between the prior pregnancy - Singleton pregnancy (home study only) - No fetal abnormality or chromosomal abnormality - Subjects willing and able to comply with requirements of the protocol Exclusion Criteria - Women who refuse to signed the informed consent form - Maternal age under 18 years old - Multiple pregnancy - Known major fetal malformation or chromosomal abnormality - Medical or obstetric problem that would preclude the use of abdominal electrodes - Inability to consent to this study due to medical illness, diminished intellectual capacity, or language barrier - Women using pacemakers |
Country | Name | City | State |
---|---|---|---|
United States | Northwestern University | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Northwestern University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Device comparison to standard monitoring | The primary outcome measure is concordance of FHR tracing assessments from Rogers sensor recordings with those obtained from the current standard of care electronic fetal monitoring systems. | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05520021 -
The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat
|
N/A | |
Recruiting |
NCT04154423 -
Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study
|
N/A | |
Completed |
NCT03785795 -
Multichannel EMG Diagnosing True Preterm Labor
|
||
Recruiting |
NCT06110143 -
Oral Health and Adverse Pregnancy Complications
|
N/A | |
Completed |
NCT05430633 -
Laparoscopic Versus Open Appendectomy in Pregnancy
|
||
Completed |
NCT03956810 -
Evaluation of the Prenatal Trip Assistance Pilot Project
|
N/A | |
Recruiting |
NCT05651347 -
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
|
Phase 3 | |
Recruiting |
NCT04332393 -
Metformin to Treat Corticosteroids-induced Hyperglycemia
|
Phase 4 | |
Completed |
NCT04074525 -
Evaluating Decisional Regret Among Mothers
|
||
Completed |
NCT02707237 -
Maternal Counseling for Preterm Deliveries, Assessing an Effective Method of Counseling
|
N/A | |
Recruiting |
NCT02166645 -
Comparison Between Preterm Infants Who Are Placed on Their Back or Stomach in the Immediate Postextubation Period
|
N/A | |
Completed |
NCT03076775 -
Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study
|
N/A | |
Recruiting |
NCT05264779 -
The Periviable GOALS Decision Support Tool
|
N/A | |
Not yet recruiting |
NCT05412056 -
Metformin to Prevent Preterm Birth in Twin Pregnancy
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04433364 -
COPE - COVID-19 in Pregnancy and Early Childhood
|
||
Completed |
NCT04989673 -
Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana
|
||
Recruiting |
NCT05345457 -
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
|
Phase 4 | |
Completed |
NCT03429257 -
Maternal EED and Aflatoxin Birth Outcomes Study Uganda
|
N/A | |
Withdrawn |
NCT03738293 -
Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
|
||
Completed |
NCT03675061 -
Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial
|
N/A |